US Patent Litigations are now available. Check here

EP3782612

CELGENE
Application Number
EP20201143A
Filing Date
May 14, 2009
Status
Granted And Under Opposition
Oct 6, 2023
Grant Date
Nov 8, 2023
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Biblio Summary

The patent EP3782612B1 was granted on Nov 8, 2023 by Celgene The patent is currently Granted And Under Opposition.

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionEP2299984B1
N/A
OppositionEP2695609B1
N/A
OppositionEP3692983B1
N/A
OppositionEP3782611B1
N/A
OppositionUS2004186065
N/A
OppositionWO2008028193
N/A
OppositionWO2011014541
N/A
OppositionWO2006034154
N/A
OppositionUS2006074046
N/A
OppositionWO2009139888
N/A

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.